From natalizumab to fingolimod in eight weeks – immunological, clinical, and radiological data in quest of the optimal switch von Harrer, Andrea, Pilz, Georg, Oppermann, Katrin, Sageder, Marlene, Afazel, Shahrzad, Haschke-Becher, Elisabeth, Rispens, Theo, de Vries, Annick, McCoy, Mark, Stevanovic, Vlado, Hitzl, Wolfgang, Trinka, Eugen, Kraus, Jörg, Sellner, Johann, Wipfler, Peter

Volltext